Zuckerman Investment Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $411K | Sell |
5,952
-1,700
| -22% | -$117K | 0.04% | 119 |
|
|
2025
Q1 | $531K | Buy |
7,652
+1,700
| +29% | +$118K | 0.06% | 109 |
|
|
2024
Q4 | $492K | Buy |
5,952
+6
| +0.1% | +$496 | 0.05% | 108 |
|
|
2024
Q3 | $708K | Buy |
5,946
+16
| +0.3% | +$1.91K | 0.07% | 83 |
|
|
2024
Q2 | $846K | Hold |
5,930
| – | – | 0.1% | 77 |
|
|
2024
Q1 | $761K | Hold |
5,930
| – | – | 0.09% | 78 |
|
|
2023
Q4 | $613K | Hold |
5,930
| – | – | 0.08% | 80 |
|
|
2023
Q3 | $539K | Buy |
5,930
+400
| +7% | +$36.4K | 0.08% | 79 |
|
|
2023
Q2 | $447K | Hold |
5,530
| – | – | 0.06% | 87 |
|
|
2023
Q1 | $440K | Hold |
5,530
| – | – | 0.07% | 82 |
|
|
2022
Q4 | $374K | Hold |
5,530
| – | – | 0.06% | 95 |
|
|
2022
Q3 | $275K | Buy |
+5,530
| New | +$275K | 0.05% | 99 |
|